Digoxin

CAS : 20830-75-5

Ref. BP-BP0490

Informations sur le produit

• Nom: Digoxin
• Synonymes: Davoxin, Digacin, Dilanacin, Lanoxin, Rougoxin, Digosin, Cordioxil, (3beta,5beta,12beta)-3-{[2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide, (3beta,5beta,8xi,9xi,12beta)-3-{[2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide, (3β,5β,12β)-3-[(O-2,6-Dideoxy-β-<span class="text-smallcaps">D</smallcap>-ribo-hexopyranosyl-(1→4)-O-2,6-dideoxy-β-<smallcap>D</smallcap>-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-β-<smallcap>D</span>-ribo-hexopyranosyl)oxy]-12,14-dihydroxycard-20(22)-enolide, 12β-Hydroxydigitoxin, Card-20(22)-enolide, 3-[(O-2,6-dideoxy-β-<span class="text-smallcaps">D</smallcap>-ribo-hexopyranosyl-(1→4)-O-2,6-dideoxy-β-<smallcap>D</smallcap>-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-β-<smallcap>D</span>-ribo-hexopyranosyl)oxy]-12,14-dihydroxy-, (3β,5β,12β)-, Card-20(22)-enolide, 3-[(O-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-O-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-β-D-ribo-hexopyranosyl)oxy]-12,14-dihydroxy-, (3β,5β,12β)-, Cardigox, Cardiogoxin, Cardioxin, Cardixin, Cardoxin, Chloroformic digitalin, Coragoxine, Digicor, Digitek, Digitoxin, 12β-hydroxy-, Digomal, Digon, Digoxin (FDA), Digoxin Nativelle, Digoxina, Digoxine, Dixina, Dokim, Dynamos, Eudigox, Fargoxin, Grexin, Homolle's digitalin, Lanacordin, Lanacrist, Lanicor, Lanikor, Lanocardin, Lanorale, Lanoxicaps, Lanoxin PG, Lenoxicaps, Lenoxin, Longdigox, Mapluxin, Natigoxin, NeoDioxanin, Novodigal-Amp., Nsc 95100, Purgoxin, Stillacor, Toloxin, Vanoxin, (3β,5β,12β)-3-[(O-2,6-Dideoxy-β-D-ribo-hexopyranosyl-(1→4)-O-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-β-D-ribo-hexopyranosyl)oxy]-12,14-dihydroxycard-20(22)-enolide

Description

Digoxin is a classical Na,K-ATPase inhibitor, with selectivity for the α2β3 isoform over the common α1β1 isoform, used in the treatment of atrial fibrillation and heart failure. Digoxin and other cardiac glycosides can inhibit hypoxia-inducible factor 1 (HIF-1)α synthesis and block tumor growth.

• Marque: Biopurify

Propriétés chimiques

• Masse moléculaire: 780.949
• Formule: C₄₁H₆₄O₁₄
• Degré de pureté: 95%~99%